Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1 (5-Year IF – 2.0)
Journal Citation Indicator (JCI) (2023) – 0.4
Scopus CiteScore – 3.7 (CiteScore Tracker 3.3)
Index Copernicus  – 161.11; MNiSW – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (PL)

Advances in Clinical and Experimental Medicine

2006, vol. 15, nr 3, May-June, p. 549–551

Publication type: review article

Language: Polish

Ocena laryngologiczna chorych na akromegalię

ENT Disorders in Acromegalic Patients

Maria Zalesska−Kręcicka1,, Tomasz Zatoński1,, Marek Bolanowski2,, Katarzyna Zatońska3,

1 Katedra i Klinika Otolaryngologii AM we Wrocławiu

2 Katedra i Klinika Endokrynologii, Diabetologii i Leczenia Izotopami AM we Wrocławiu

3 Katedra i Zakład Medycyny Społecznej AM we Wrocławiu

Streszczenie

Akromegalia jest rzadką chorobą, której objawy są spowodowane nadmiernym wydzielaniem hormonu wzrostu (GH) przez łagodny guz przedniego płata przysadki mózgowej – gruczolak. Autorzy przedstawiają dane z piśmiennictwa dotyczące dotychczasowych badań wpływu choroby na dysfunkcję: ucha, nosa, zatok, gardła i krtani.

Abstract

Acromegaly is a rare disease, which symptoms are caused by growth hormone (GH) secretion in excess from anterior pituitary benign tumour – adenoma. Authors present literature data referred to ENT disorders in acromegalic patients.

Słowa kluczowe

akromegalia, otolaryngologia, bezdechy śródsenne, niedosłuch

Key words

acromegaly, ENT, SAS, hearing disorders

References (26)

  1. Marie P: Sur deux cas d’acromegalie: hypertrophie singuliere, non congenitale, des extremites superieures, inferieures et cephalique. Revue Medicale de Liege 1886, 6, 297–333.
  2. Nabarro JDN: Acromegaly. Clin Endocrinol 1987, 26, 481–512.
  3. Molitch M: Clinical manifestations of acromegaly. Endocrinol Metab Clin North Am 1992, 21, 597–614.
  4. Bolanowski M, Schopohl J, Marciniak M, Rzeszutko M, Zatońska K, Daroszewski J, Milewicz A, Malczewska J, Badowski R: Acromegaly due to GHRH−secreting large bronchial carcinoid. Complete recovery following tumor surgery. Exp Clin Endocrinol Diabetes 2002, 110, 188–192.
  5. Losa M, von Werder K: Pathophysiology and clinical aspects of the ectopic GH−releasing hormone secretion. Clin Endocrinol 1997, 47, 123–135.
  6. Monson JP: The epidemiology of endocrine tumours. Endocr Relat Cancer 2000, 7, 29–36.
  7. Bengtsson BA, Eden S, Ernest I, Oden A, Sjogren B: Epidemiology and long−term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand 1988, 223, 327–335.
  8. Ezzat S, Melmed S: Are patients with acromegaly at increased risk for neoplasia? J Clin Endocrinol Metab 1991, 72, 245–249.
  9. Bates AS, Van’t Hoff W, Jones JM, Clayton RN: Does treatment of acromegaly affecty life expectancy. Metabolism 1995, 44, suppl. 1, 1–5.
  10. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE: The effects of insulin−like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 2000, 21, 215–244.
  11. Cats A, Dullaart RPF, Kleibeuker JH, Kuipers F, Sluiter WJ, Hardonk MJ, de Vries EGE: Increased epithelial cell proliferation in the colon of patients with acromegaly. Cancer Res 1996, 56, 523–526.
  12. Jenkins PJ: Acromegaly and colon cancer. Growth Horm IGF Res 2000, Suppl. A, 35–36.
  13. Chappell WF, Booth JA: A case of acromegaly with laryngeal and pharyngeal symptoms. J Laryng Otol 1896, 10, 142–150.
  14. Weiss V, Sonka K, Pretl M, Dostalova S, Klozar J, Rambousek P, Marek J, Haas T: Prevalence of sleep apnea syndrome in acromegaly population. J Endocrinol Invest 2000, 23, 515–519.
  15. Mickelson SA, Rosenthal LD, Rock JP, Senior BA, Friduss ME: Obstructive sleep apnea syndrome and acromegaly. Otolaryngol Head Neck Surg 1994, 111, 25–30.
  16. Mezon BJ, West P, MaClean JP, Kryger MH: Sleep apnea in acromegaly. Am J Med 1980, 69, 615–618.
  17. Cadieux RJ, Kales A, Santen RJ, Bixler EO, Gordon R: Endoscopic findings in sleep apnoea associated with acromegaly. J Clin Endocrinol Metab, 1982, 55, 18–22.
  18. Goldhill DR, Dalgleish JG, Lake RHN: Respiratory problems and acromegaly. Anaesthesia 1982, 37, 1200–1203.
  19. Skinner DW, Richards SH: Acromegaly – the mucosal changes within the nose and paranasal sinuses. J Laryngol Otol 1988, 102, 1107–1110.
  20. Maj J, Materlich H, Szymczyk K: Zagadnienie akromegalii w otolaryngologii. Otolaryngol Pol 1965, 19, 497–500.
  21. Menzel O: Hearing loss secondary to acromegaly: case report. Eye Ear Nose Throat Mon 1966, 45, 84–85.
  22. Doig JA, Gatehouse S: Hearing in acromegaly. J Laryngol Otol 1984, 98, 1097–1101.
  23. Richards S: Deafness in acromegaly. J Laryngol Otol 1968, 82, 1053–1065.
  24. Graham MD, Brackmann DE: Acromegaly and the temporal bone. J Laryngol Otol 1978, 92, 275–279.
  25. Williams RG, Richards SH, Mills RG, Eccles R: Voice changes in acromegaly. Laryngoscope 1994, 104 (4), 484–487.
  26. Williams RG, Eccles R: A new clinical measure of external laryngeal size which predicts the fundamental frequency of the farynx. Acta Otolaryngol (Stockh) 1990, 110, 141–148.